Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...
Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...
India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...
Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...
The drug is expected to offer nerve regeneration, potentially modifying the disease in diabetic peripheral neuropathy ...
Alkem Laboratories said that it has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, to develop, manufacture and commercialise the drug candidate 'SON-080' for the ...
Alkem Laboratories has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc (Sonnet) to develop, manufacture and commercialise the drug candidate SON-080 for the ...
The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback